|Grant Affiliation:||Ho: Enhancing Innate Immune Activation|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2009-06-02|
|Study Made Public:||NA|
CAVD 300 is an immunogenicity study to evaluate and characterize the neutralization activity in serum from a panel of HIV-infected individuals.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.